West Pharmaceutical Services Inc
Close on Nov 20, 2026Market cap $27.19BP/E 43.8Yield 0.22%
West Pharmaceutical Services Ongoing EU GMP Annex 1 / HVP Customer Upgrade Projects by Quarter
West Pharmaceutical Services Ongoing EU GMP Annex 1 / HVP Customer Upgrade Projects: 325 in Q4 2025.
Where the Q4 2025 figure comes from
“325 projects are ongoing”
Source: West Form 8-K (FY2025Q4, filed 2026-02-12) ↗
Active customer conversion projects upgrading standard stoppers and seals to Westar/NovaPure/FluroTec High-Value Products under EU GMP Annex 1 sterility rules.
quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Ongoing EU GMP Annex 1 / HVP Customer Upgrade Projects | Year on year | Source |
|---|---|---|---|---|
| Q4 2025 | Dec 31, 2025 | 325 | – | West Form 8-K (FY2025Q4, filed 2026-02-12) ↗ |
| Q3 2025 | Sep 30, 2025 | 375 | – | West Form 8-K (FY2025Q3, filed 2025-10-23) ↗ |
| Q2 2025 | Jun 30, 2025 | 370 | – | West Form 8-K (FY2025Q2, filed 2025-07-24) ↗ |
| Q1 2025 | Mar 31, 2025 | 340 | – | West Form 8-K (FY2025Q2, filed 2025-07-24) ↗ |
Cite this data
StockData. (2026). West Pharmaceutical Services Ongoing EU GMP Annex 1 / HVP Customer Upgrade Projects, quarterly Q1 2025–Q4 2025 [Data set]. Compiled from West Pharmaceutical Services SEC filings and investor materials. https://stockdatahq.com/stocks/wst/kpis/annex1-ongoing-projects
See every metric in the West Pharmaceutical Services KPI table. Data updated Nov 9, 2026.
See a number that looks wrong?